Search
Alanine
go.drugbank.com/drugs/DB00160ApprovedInvestigationalNutraceuticalIt is involved in sugar and acid metabolism, increases immunity, and provides energy for muscle tissue, brain, and the central nervous system.
Mixtures: GLAMIN SOLUTION FOR INFUSION, KABIVEN EMULSION FOR INFUSIONLetterer-Siwe disease
go.drugbank.com/conditions/DBCOND0021755Drugs: VinblastineSynonyms: Langerhans cell histiocytosis, no International Classification of Diseases for Oncology subtypeLymphoma, Diffuse
go.drugbank.com/conditions/DBCOND0036855Synonyms: Non-Hodgkin lymphoma, no International Classification of Diseases for Oncology subtypeNon-Hodgkin's Lymphoma (NHL)
go.drugbank.com/conditions/DBCOND0030854Synonyms: Non-Hodgkin lymphoma, no International Classification of Diseases for Oncology subtypeParitaprevir
go.drugbank.com/drugs/DB09297ApprovedInvestigationalHCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients [L852]. … First approved in January 2015, Holkira Pak is indicated for the treatment of HCV genotype 1b with or without cirrhosis, and when combined with [DB00811] for the treatment of HCV genotype 1a with or without
Categories: Antivirals for Systemic Use, Antiinfectives for Systemic UseZinc acetate
go.drugbank.com/drugs/DB14487ApprovedInvestigationalMixtures: OMEGA PLUS EMULSION FOR INFUSION, Johnson and Johnson All Purpose First Aid KitCategories: Agents for Treatment of Hemorrhoids and Anal Fissures for Topical UseThrombin
go.drugbank.com/drugs/DB11300ApprovedInvestigationalPatients who are administered bovine thrombin should be monitored for abnormal coagulation laboratory values, bleeding, or indeed, thrombosis [FDA Label]. … Thrombin requires no intermediate physiological agent for its action. It clots the fibrinogen of the blood directly.
Mixtures: Artiss Solutions for Sealant, Deep Frozen, ARTISS - Lösungen für einen GewebekleberIbalizumab
go.drugbank.com/drugs/DB12698ApprovedInvestigationalThis drug was approved in March 2018 for the management of treatment-resistant HIV [L1554]. … In October 2022, the FDA approved the administration of Trogarzo (ibalizumab-uiyk) by intravenous push, allowing for a faster drug administration.[L43443,L43448]
Categories: Antivirals for Systemic Use, Antiinfectives for Systemic UseProtein C
go.drugbank.com/drugs/DB11312ApprovedInvestigationalProtein C is available in concentrated form as the product Ceprotin, which is indicated for use in pediatric and adult patients with severe congenital protein C deficiency for the prevention and treatment … The Protein C pathway provides a natural mechanism for control of the coagulation system and prevention of excessive procoagulant responses to activating stimuli.
Mixtures: OCTAPLEX POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 500 IU, BERIPLEX P/N 500 POWDER FOR SOLUTION FOR INJECTIONSulfathiazole
go.drugbank.com/drugs/DB06147ApprovedVet approvedWithdrawnExcept for those formulated for vaginal use, the FDA withdrew its approval for the use of all drug products containing sulfathiazole.[L43942]
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use